Y-Biologics, Inc. (KOSDAQ:338840)
South Korea
· Delayed Price · Currency is KRW 23,950
+1,100 (4.81%)
At close: Mar 6, 2026
Y-Biologics Revenue
Y-Biologics had revenue of 892.40M KRW in the quarter ending September 30, 2025, a decrease of -72.46%. This brings the company's revenue in the last twelve months to 3.61B, down -30.96% year-over-year. In the year 2024, Y-Biologics had annual revenue of 5.76B with 65.64% growth.
Revenue (ttm)
3.61B
Revenue Growth
-30.96%
P/S Ratio
96.45
Revenue / Employee
n/a
Employees
n/a
Market Cap
348.34B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| curacle co.,ltd. | 1.14B |
| NIBEC | 32.96B |
| S.Biomedics | 16.96B |
| Bio Solution | 8.27B |
| ABION | 1.03B |
| Genome & Company | 25.95B |
| ISU Abxis | 66.39B |
| IntoCell | 1.68B |